FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308335887> ?p ?o ?g. }

• W4308335887 endingPage "2179" @default.
• W4308335887 startingPage "2179" @default.
• W4308335887 abstract "Osteoporosis, or bone loss, is a disease that affects many women globally. As life expectancy increases, the risk of osteoporosis in women also increases, too, and this will create a burden on the healthcare and economic sectors of a country. Osteoporosis was once thought to be a disease that would occur only after menopause. However, many studies have shown that osteoporosis may develop even in the perimenopausal stage. Due to the erratic levels of estrogen and progesterone during the perimenopausal stage, studies suggest that women are exposed to the risk of developing osteoporosis even at this stage. The erratic hormonal changes result in the production of proinflammatory mediators and cause oxidative stress, which leads to the progressive loss of bone-building activities. Tocotrienols, members of vitamin E, have many health-promoting properties. Due to their powerful anti-oxidative and anti-inflammatory properties, tocotrienols have shown positive anti-osteoporotic properties in post-menopausal studies. Hence, we propose here that tocotrienols could also possibly alleviate perimenopausal osteoporosis by discussing in this review the connection between inflammatory mediators produced during perimenopause and the risk of osteoporosis. Tocotrienols could potentially be an anti-osteoporotic agent, but due to their low bioavailability, they have not been as effective as they could be. Several approaches have been evaluated to overcome this issue, as presented in this review. As the anti-osteoporotic effects of tocotrienols were mostly studied in post-menopausal models, we hope that this review could pave the way for more research to be done to evaluate their effect on peri-menopausal models so as to reduce the risk of osteoporosis from an earlier stage." @default.
• W4308335887 created "2022-11-11" @default.
• W4308335887 creator A5012207972 @default.
• W4308335887 creator A5026996000 @default.
• W4308335887 creator A5040081813 @default.
• W4308335887 creator A5058116134 @default.
• W4308335887 creator A5065580449 @default.
• W4308335887 date "2022-11-03" @default.
• W4308335887 modified "2023-10-18" @default.
• W4308335887 title "Ameliorative Effect of Tocotrienols on Perimenopausal-Associated Osteoporosis—A Review" @default.
• W4308335887 cites W1587007485 @default.
• W4308335887 cites W1848472769 @default.
• W4308335887 cites W1909885733 @default.
• W4308335887 cites W1965837047 @default.
• W4308335887 cites W1967291007 @default.
• W4308335887 cites W1969323709 @default.
• W4308335887 cites W1978961990 @default.
• W4308335887 cites W1980611990 @default.
• W4308335887 cites W1981803131 @default.
• W4308335887 cites W1986219537 @default.
• W4308335887 cites W1992132514 @default.
• W4308335887 cites W1994064108 @default.
• W4308335887 cites W1998386661 @default.
• W4308335887 cites W2001487573 @default.
• W4308335887 cites W2021584909 @default.
• W4308335887 cites W2022822304 @default.
• W4308335887 cites W2029616854 @default.
• W4308335887 cites W2041425125 @default.
• W4308335887 cites W2045820195 @default.
• W4308335887 cites W2051707833 @default.
• W4308335887 cites W2060329407 @default.
• W4308335887 cites W2065495428 @default.
• W4308335887 cites W2077093985 @default.
• W4308335887 cites W2090792221 @default.
• W4308335887 cites W2092222515 @default.
• W4308335887 cites W2094087197 @default.
• W4308335887 cites W2097481089 @default.
• W4308335887 cites W2100297973 @default.
• W4308335887 cites W2101051981 @default.
• W4308335887 cites W2102958667 @default.
• W4308335887 cites W2103441192 @default.
• W4308335887 cites W2107490395 @default.
• W4308335887 cites W2112827108 @default.
• W4308335887 cites W2114610268 @default.
• W4308335887 cites W2116828737 @default.
• W4308335887 cites W2140605096 @default.
• W4308335887 cites W2153795968 @default.
• W4308335887 cites W2155173096 @default.
• W4308335887 cites W2155415200 @default.
• W4308335887 cites W2159664024 @default.
• W4308335887 cites W2215653021 @default.
• W4308335887 cites W2325089636 @default.
• W4308335887 cites W2480939959 @default.
• W4308335887 cites W2541108990 @default.
• W4308335887 cites W2579705245 @default.
• W4308335887 cites W2599867508 @default.
• W4308335887 cites W2761025268 @default.
• W4308335887 cites W2786716257 @default.
• W4308335887 cites W2951801120 @default.
• W4308335887 cites W2992035849 @default.
• W4308335887 cites W3000647780 @default.
• W4308335887 cites W3131740586 @default.
• W4308335887 cites W3212927343 @default.
• W4308335887 cites W3217156508 @default.
• W4308335887 cites W4220955706 @default.
• W4308335887 cites W4234708959 @default.
• W4308335887 cites W4253165656 @default.
• W4308335887 cites W4283207238 @default.
• W4308335887 cites W820173156 @default.
• W4308335887 cites W2336948427 @default.
• W4308335887 doi "https://doi.org/10.3390/antiox11112179" @default.
• W4308335887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36358550" @default.
• W4308335887 hasPublicationYear "2022" @default.
• W4308335887 type Work @default.
• W4308335887 citedByCount "1" @default.
• W4308335887 countsByYear W43083358872023 @default.
• W4308335887 crossrefType "journal-article" @default.
• W4308335887 hasAuthorship W4308335887A5012207972 @default.
• W4308335887 hasAuthorship W4308335887A5026996000 @default.
• W4308335887 hasAuthorship W4308335887A5040081813 @default.
• W4308335887 hasAuthorship W4308335887A5058116134 @default.
• W4308335887 hasAuthorship W4308335887A5065580449 @default.
• W4308335887 hasBestOaLocation W43083358871 @default.
• W4308335887 hasConcept C124490489 @default.
• W4308335887 hasConcept C126322002 @default.
• W4308335887 hasConcept C133925201 @default.
• W4308335887 hasConcept C185592680 @default.
• W4308335887 hasConcept C1862650 @default.
• W4308335887 hasConcept C2776541429 @default.
• W4308335887 hasConcept C2777164284 @default.
• W4308335887 hasConcept C2777551382 @default.
• W4308335887 hasConcept C2778004101 @default.
• W4308335887 hasConcept C2778310972 @default.
• W4308335887 hasConcept C2778562196 @default.
• W4308335887 hasConcept C2779134260 @default.
• W4308335887 hasConcept C2781449162 @default.
• W4308335887 hasConcept C2908647359 @default.
• W4308335887 hasConcept C55493867 @default.

• next